ANN WATSON: Open Payments
NPI 1912089095 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 17 payments from 9 companies in 2025. Trend: 2023 $65 · 2024 $49 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| ABBVIE INC. | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Exeltis, USA Inc. | 1 | $14 |
Products named: NEXPLANON, MYFEMBREE, LILETTA, Veozah, NOVASURE, Bulkamid, Cologuard Collection Kit, SLYND.
Industry payments across KY — which companies pay providers there.
